Impact (2) toxicité (1) qualité de vie (1) industrie pharmaceutique (1) besoin (1) marketing (1) démocratie (1) décision (1) coût (1) cancer (1) survie (1) Mortality (1) Diagnosis (1) Decision making (1) Context (1) Marketing (1) Treatment (1) Cost effectiveness (1) Cancer (1) Assaying (1) Methodology (1) Methods (1) Interviews (1) Transparency (1) Expertise (1) Wealth (1) Views (1) Survival (1) Strategy (1) Risk (1)